- Tech Companies Just Reported Earnings. What to Know. (Barron’s)
- Facebook Stock Slips After Earnings. They Were Good but the Outlook Isn’t Rosy. (Barron’s)
- Alphabet Sales Growth Returns to Pre-Pandemic Level. The Stock Is Soaring. (Barron’s)
- Stocks Fell on Covid Fears. Treasury Yields Didn’t Follow Along. (Barron’s)
- How to Use the Election to Buy Stocks at a Bargain Price (Barron’s)
- After the Election, Managed-Care Stocks Tend to Rise. Anthem Is a Good Candidate for a Run. (Barron’s)
- U.S., China Friction Will Persist After the Election. Here’s What Investors Should Expect. (Barron’s)
- Here are 5 quality ‘election-proof’ stocks with upside potential, analyst says (MarketWatch)
- GDP Growth Was Massive. (Barron’s)
- Exxon to Slash U.S. Workforce (Barron’s)
- Apple iPhone Delay Hurt China Sales, Leaving a Lot Riding on 5G (Bloomberg)
- Megacap Tech Disappoints Market Where Nothing’s Good Enough (Bloomberg)
- At least until the pandemic, the president’s unconventional policy got unprecedented results. (Bloomberg)
- Dr. Paul Marik: Ivermectin Works and Should be Accepted for Large Observational Studies (TrialSiteNews)
- Gilead’s Covid-19 Drug Is Mediocre. It Will Be a Blockbuster Anyway. (New York Times)
- In Battleground Pennsylvania, Fracking and Renewables Compete to Be the Future of Energy (Wall Street Journal)
- Shell Tries to Woo Investors With Dividend Raise, Promise of Future Payouts (Wall Street Journal)